AFCarl Zeiss AFX.DE · XETRA
35.44 € -0.28% (-0.10 €)
- Market cap
- 3.05B €
- Enterprise value
- 3.05B €
- P/E
- 26.2x
- Forward P/E
- 24.0x
- PEG
- -
- P/S
- 1.2x
- P/FCF
- 11.2x
- EV/EBITDA
- 9.2x
- ROIC
- -
- Gross margin
- 51.0%
- Net margin
- 4.4%
- Dividend yield
- 1.58%
- Payout ratio
- 41.3%
- Net debt/EBITDA
- 0.0x
- Beta
- 1.33
- Free float
- 39.1%
About the company
Carl Zeiss Meditec AG is a German company headquartered in Jena, specializing in the development, manufacturing, and sale of medical technologies and devices for ophthalmology and neurosurgery. Their products include advanced diagnostic and surgical systems such as ophthalmic microscopes, laser systems for vision correction, diagnostic examination devices, and image analysis software. Carl Zeiss Meditec is known for its innovative technologies and high quality products that contribute to the treatment of eye diseases and neurosurgical procedures. The company has a global presence and is recognized as a leader in the field of ophthalmic and neurosurgical medical technologies. Shares of Carl Zeiss Meditec AG are publicly traded on the German stock exchange.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Andreas Pecher
Employees
5,784
Headquarters
Jena
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Earnings per share fell by 21% a year over the last 3 years.
- What to watch: It missed profit estimates 4 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
- What speaks for it: It could repay all its net debt from 0.0 years of operating profit.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number